Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 19, 2018
Conatus Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) has accepted invitations to participate in two upcoming investor conferences. At the Oppenheimer ...
September 19, 2018
Soleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease
REDWOOD CITY, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
September 19, 2018
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM) today announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the joint development of ...
September 19, 2018
AIT Therapeutics Presented Nitric Oxide Data at the European Respiratory Society International Congress 2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 19, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on ...
September 19, 2018
Achaogen Announces Multiple Plazomicin Presentations at IDWeek 2018
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing, and commercializing innovative antibacterials addressing multi-drug resistant ...
September 19, 2018
Zosano Pharma Completes Manufacture of M207 Registration Batches
FREMONT, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration ...
September 19, 2018
Neovasc Announces 100th Patient to Receive Reducer Therapy in Germany
VANCOUVER, Sept. 19, 2018 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NVCN) (NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve ...
September 19, 2018
Transgene Presents 2018 Half-Year Results and Business Update
Transgene (TNG.PA) (Euronext Paris: TNG), Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancers and infectious diseases, announces its ...
September 18, 2018
Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to MOB-015 from Moberg Pharma for the topical treatment of Onychomycosis
MISSISSAUGA,ON, Sept. 18, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (CPH.TO) today  announced it has acquired the exclusive Canadian rights to commercialize, promote, sell and distribute ...
September 18, 2018
BioTime Implements New Leadership Structure; Appoints Brian Culley as Chief Executive Officer
BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that the Board of Directors has implemented a new leadership ...
September 18, 2018
Tyme Appoints Accomplished Healthcare Executive Douglas A. Michels to Board of Directors
NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) --  Tyme Technologies, Inc. (TYME), a clinical-stage biotechnology company developing cancer therapeutics, today announced the appointment of Douglas ...
September 18, 2018
Relmada Therapeutics Provides Enrollment Update in Phase 2 Study of REL-1017 in Patients with Major Depressive Disorder
NEW YORK, Sept. 18, 2018 /PRNewswire/ -- Relmada Therapeutics, Inc. (RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) ...
September 18, 2018
DURECT Announces Methydur Sustained Release Capsules Receive Marketing Authorization for ADHD in Taiwan
CUPERTINO, Calif., Sept. 18, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) today announced that Orient Pharma Co., Ltd., its licensee for certain Asian and South Pacific countries, ...
September 18, 2018
Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address ...
September 18, 2018
Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
Copenhagen, September 18, 2018 - Zealand Pharma A/S ("Zealand") (ZEAL.CO), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces ...
September 18, 2018
Foamix Announces Closing of its Follow-on Offering of Ordinary Shares and Full Exercise of its Option by the Underwriters
REHOVOT, Israel, and BRIDGEWATER, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (“Foamix”) (FOMX), a clinical-stage specialty pharmaceutical company focused on developing and ...
September 17, 2018
VBL Therapeutics to Present at Upcoming Conferences in October
TEL AVIV, Israel, Sept. 17, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of ...
September 17, 2018
Soleno Therapeutics to Present DCCR Clinical Data at Late Breaking Sessions of the European Society for Paediatric Endocrinology
REDWOOD CITY, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
September 17, 2018
STRATA Skin Sciences to Participate in Panel Discussion at The MedTech Conference
HORSHAM, Pa., Sept. 17, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
September 17, 2018
InspireMD Announces Issuance of Two New U.S. Patents Covering Proprietary MicroNet™ Stent Jacket and Related Drug Eluting Technology
TEL AVIV, Israel, Sept. 17, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
Page 18 of 117